Khalifa E. Sharquie
About
In The Last Decade
Khalifa E. Sharquie
152 papers receiving 1.7k citations
Peers
Comparison fields: 5 of 116
- Dermatology 633
- Public Health, Environmental and Occupational Health 418
- Epidemiology 389
- Cell Biology 292
- Ophthalmology 234
Countries citing papers authored by Khalifa E. Sharquie
This map shows the geographic impact of Khalifa E. Sharquie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalifa E. Sharquie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalifa E. Sharquie more than expected).
Fields of papers citing papers by Khalifa E. Sharquie
This network shows the impact of papers produced by Khalifa E. Sharquie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalifa E. Sharquie. The network helps show where Khalifa E. Sharquie may publish in the future.
Co-authorship network of co-authors of Khalifa E. Sharquie
This figure shows the co-authorship network connecting the top 25 collaborators of Khalifa E. Sharquie. A scholar is included among the top collaborators of Khalifa E. Sharquie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalifa E. Sharquie. Khalifa E. Sharquie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | Ivermectin Cream is more Effective and Rapid than Permethrin Cream in Treatment of Patients with Scabies | 1 |
| 3 | Clinical and Histopathological Evaluation of Pigmented Morphea with New Insight in Relation to Etiopathogenesis of the Disease | 1 |
| 4 | Imiquimod Cream in Low Concentrations as a New Topical Therapy for Melasma | 1 |
| 5 | Methotrexate in Low Split dose as a First Line Treatment Option in the Management of Early Mycosis Fungoides | 1 |
| 6 | Kaposi Sarcoma is Increasing over Years | 0 |
| 7 | Intralesional Injection of Hyaluronic Acid as a Long Lasting Therapy of Morphea Sclerosis | 3 |
| 8 | A Case of Porokeratosis of Hands and Feet Turning into a Squamous Cell Carcinoma | 0 |
| 9 | Sesame and Pumpkin Seed Oil are New Effective Topical Therapies for Alopecia Areata | 2 |
| 10 | Zinc Sulphate 5%Mouthwash is an Effective Therapeutic and Prophylactic Agent in Treatment of Recurrent Aphthous Ulcer (Single blind placebo controlled therapeutic study) | 1 |
| 11 | Treatment of Vitiligo with Topical 5% Tincture Iodine and UVA Light | 1 |
| 12 | Treatment of Tinea Corporis by Topical 10% Zinc Sulfate Solution | 2 |
| 13 | Efficacy and Safety of Topical Podophyllin 5% Ointment in Patients with Mild Plaque-Type Psoriasis | 2 |
| 14 | Lactic Acid 5% Mouthwash is an Effective Therapeutic and Prophylactic Agent in Treatment of Recurrent Aphthous Ulcer (Single blind placebo controlled therapeutic study) | 0 |
| 15 | The frequency of 21-alpha hydroxylase enzyme deficiency and related sex hormones in Iraqi healthy male subjects versus patients with acne vulgaris. | 7 |
| 16 | Scarring and None Scarring Facial Acne Vulgaris and the Frequency of Associated Skin Diseases | 2 |
| 17 | Female Pattern Alopecia and Lipoproteins | 1 |
| 18 | Treatment of Pityriasis Versicolour with Topical 15% Zinc Sulfate Solution | 8 |
| 19 | Topical Therapy of Xeroderma Pigmentosa with 20% Zinc Sulfate Solution | 4 |
| 20 | Antioxidants Use of Vitamin C and vitamin E in Patients with Vitiligo | 0 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.